Your browser doesn't support javascript.
loading
Cyclophosphamide plus etoposide is a safe and effective mobilization regimen in patients with multiple myeloma.
Heider, Michael; Grass, Sandra; Dill, Veronika; Rämisch, Stephanie; Winter, Christof; Verbeek, Mareike; Götze, Katharina S; Bassermann, Florian; Jilg, Stefanie.
Afiliación
  • Heider M; Medical Department III for Hematology and Oncology, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Germany; Center for Translational Cancer Research (TranslaTUM), Klinikum rechts der Isar, Technical University of Munich, Germany.
  • Grass S; Medical Department III for Hematology and Oncology, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Germany.
  • Dill V; Medical Department III for Hematology and Oncology, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Germany.
  • Rämisch S; Medical Department III for Hematology and Oncology, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Germany.
  • Winter C; Institute of Clinical Chemistry and Pathobiochemistry, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
  • Verbeek M; Medical Department III for Hematology and Oncology, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Germany.
  • Götze KS; Medical Department III for Hematology and Oncology, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Germany; Deutsches Konsortium für Translationale Krebsforschung (DKTK), 69120 Heidelberg, Germany.
  • Bassermann F; Medical Department III for Hematology and Oncology, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Germany; Center for Translational Cancer Research (TranslaTUM), Klinikum rechts der Isar, Technical University of Munich, Germany; Deutsches Konsortium für Translationale
  • Jilg S; Medical Department III for Hematology and Oncology, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Germany. Electronic address: stefanie.jilg@tum.de.
Transfus Apher Sci ; 60(5): 103197, 2021 Oct.
Article en En | MEDLINE | ID: mdl-34175195
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Células Madre Hematopoyéticas / Protocolos de Quimioterapia Combinada Antineoplásica / Movilización de Célula Madre Hematopoyética / Ciclofosfamida / Trasplante de Células Madre de Sangre Periférica / Etopósido / Mieloma Múltiple Tipo de estudio: Guideline / Observational_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Transfus Apher Sci Asunto de la revista: HEMATOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Células Madre Hematopoyéticas / Protocolos de Quimioterapia Combinada Antineoplásica / Movilización de Célula Madre Hematopoyética / Ciclofosfamida / Trasplante de Células Madre de Sangre Periférica / Etopósido / Mieloma Múltiple Tipo de estudio: Guideline / Observational_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Transfus Apher Sci Asunto de la revista: HEMATOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Alemania